|
【结 构 式】 
|
【药物名称】D-7193 (as di-L-lysine salt), D-7042, H-327/86 【化学名称】N,N'-Diacetyl-L-cystine 【CA登记号】139602-29-2 【 分 子 式 】C10H16N2O6S2 【 分 子 量 】324.37682 |
【开发单位】AstraZeneca (Originator) 【药理作用】Atherosclerosis Therapy, CARDIOVASCULAR DRUGS, IMMUNOMODULATING AGENTS, Immunomodulators, Treatment of Disorders of the Coronary Arteries and Atherosclerosis |
合成路线1
The title compound may be prepared either by acetylation of L-cystine (I) or by oxidative dimerization of N-acetylcysteine (II).
| 【1】 Andersson, C.-M.A.; Bergstrand, S.H.A.; Hallberg, A.R.; Särnstrand, B.O.; Tunek, P.A.S. (AstraZeneca plc); The pharmacological use of certain cystine derivs.. EP 0463514; EP 0532595; EP 0727207; JP 1992230359; JP 1993507705; US 5441976; US 5780508; WO 9118594 . |
Extended Information